Discover
CGEN
Compugen Ltd.
2.13
2 x 1.56
2 x 2.72
bid
ask
-
0.01
0.47%
2 @ 04:01 AM
2.06 -0.07 (3.29%)
| Ytd | 39.22% | |
| 1y | 23.12% |
2.10
day range
2.18
1.30
52 week range
3.24
| Open | 2.17 | Prev Close | 2.14 | Low | 2.10 | High | 2.18 | Mkt Cap | 201.47M |
| Vol | 172.31K | Avg Vol | 498.07K | EPS | 0.38 | P/E | 5.61 | Forward P/E | -13.82 |
| Beta | 2.65 | Short Ratio | 6.42 | Inst. Own | 14.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 2.48 | 200-d Avg | 1.99 | 1yr Est | 4.00 |
CGEN News
benzinga.com
Compugen Presents Trial-In-Progress Poster On MAIA-Ovarian Adaptive Platform Trial Of COM701, Potent
Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer
benzinga.com
Compugen To Present Trial-In-Progress Poster On MAIA-Ovarian Phase 1 Study Of COM701, Anti-PVRIG Ant
Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer
benzinga.com
Compugen Q1 2026 Earnings Call: Complete Transcript